Product Description
| Cat Number | T36646 |
|---|---|
| Category | Biochemical |
| Pack Size | 1EA |
| Description | Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd). Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer. |
| Molecular Weight | 145 kDa (average) |
| Purity | SEC-HPLC:98.49% |
| Storage | -20 ℃ |
| View Document | |
| Note | This product is for Research Use Only |
Share Item: